Mannose binding lectin and macrophage migration inhibitory factor gene polymorphisms in Turkish children with cardiomyopathy: No association with MBL2 CODON 54 A/B genotype, but an association between MIF -173 cc genotype

International Journal of Medical Sciences

Volumn 9, Issue 6, 2012, Pages 506-512

  Col Araz, Nilgun ^a   Oguzkan Balci, Sibel ^a   Baspinar, Osman ^a   Sever, Tugce ^a   Balat, Ayse ^a   Pehlivan, Sacide ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Cardiomyopathy; Children; Macrophage migration inhibitory factor; Mannose binding lectin; Polymorphism

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; MANNOSE BINDING LECTIN 2; SODIUM; URIC ACID;

ADOLESCENT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR PARAMETERS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CODON; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE DURATION; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; ETHNIC GROUP; FRACTIONAL SHORTENING; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC DIAMETER; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC DIAMETER; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFANT; MACROPHAGE MIGRATION INHIBITION FACTOR GENE; MANNOSE BINDING LECTIN 2 GENE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTIVE CARDIOMYOPATHY; RISK ASSESSMENT; SODIUM BLOOD LEVEL; TURKISH; URIC ACID BLOOD LEVEL;

ADOLESCENT; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MANNOSE-BINDING LECTIN; POLYMORPHISM, GENETIC; TURKEY;

EID: 84866014143     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.4787     Document Type: Article

References (40)

1. Nugent AW, Daubeney DE, Chandras P, et al. National Australian Childhood Cardiomiyopathy Study. The epidemiology of childhood cardiomiyopathy in Australia. N Engl J Med. 2003; 348: 1639-1646.
2. Lipshultz SE, Sleeper TA, Towbin JA, et al. The incidence of pediatric cardiomiyopathy in two regions of the United States. N Engl J Med. 2003; 348: 1647-1655.
3. Maisch B, Richter A, Sandmoller A, BMBF - Herth Failure Network. Inflammatory dilated cardiomyopathy (DCMI). Herz 2005; 30: 535-544.
4. Renner P, Roger T, Calandra T. Macrophage migration inhibitory factor: Gene polymorphisms and suspectibility to inflammatory diseases. Clin Infect Dis. 2005; 41: 513-519.
5. Ruskamp JM, Hoekstra MO, Rovers MM, et al. Mannose-binding lectin and upper respiratory tract infections in children and adolescents. Arch Otolaryngol Head Neck Surg. 2006;132: 482-486.
6. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol. 2003; 40: 423-429.
7. Garred P, Madsen HO, Halberg P, et al. Mannose-binding lectin poly-morphisms and susceptibility to infection in systemic lupus erythema-tosus. Arthritis Rheum 1999; 42: 2145-152.
8. Ip WK, Lau L, Chan SY, et al. Mannose-binding lectin and rheumatoid arthritis in Southern Chinese. Arthritis Rheum. 2000; 43: 1679-1687.
9. Zou C, La Bonte LR, Pavlov VI, et al. Murine hyperglycemic vasculopa-thy and cardiomyopathy: whole-genome gene expression analysis pre-dicts cellular targets and regulatory networks influenced by mannose binding lectin. Front Immunol. 2012; 3:15.
10. Pavlov VI, La Bonte LR, Baldwin WM, et al. Absence of man-nose-binding lectin prevents hyperglycemic cardiovascular complications. Am J Pathol. 2012; 180:104-112.
11. Busche MN, Walsh MC, McMullen ME, et al. Mannose-binding lectin plays a critical role in myocardial ischaemia and reperfusion injury in a mouse model of diabetes. Diabetologia. 2008; 51: 1544-1551.
12. Schafranski MD, Ferrari LP, Scherner D, et al. High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever. Mol Immunol. 2008; 45: 3827-3831.
13. Yu XY, Chen HM, Liang JL, et al. Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor. PLoS One. 2011; 25:e16239.
14. Berdeli A, Ozyürek AY, Ulger Z, et al. Association of macrophage migration inhibitory factor gene -173G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis. Rheumatol Int. 2006; 26: 726-731.
15. Lan HY, Yang N, Nikolic- Paterson DJ, et al. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int. 2000; 57: 499-509.
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215.
17. Vardar F, Pehlivan S, Onay H, et al. Association between mannose binding lectin polymorphisms and predisposition to bacterial meningitis. Turk J Pediatr. 2007; 49: 270-273.
18. Akcali A, Pehlivan S, Pehlivan M, et al. Association of macrophage migration inhibitory factor gene promoter polymorphisms with multiple sclerosis in Turkish patients. J Int Med Res. 2010; 38: 69-77.
19. [Internet] Strom TM, Wienker TF. Hardy-Weinberg equilibrium online analysis program. http:/ihg.gsf.de/cgi-bin/hw/hwa2.pl
20. Col-Araz N, Pehlivan S, Baspinar O, et al. Association of macrophage migration inhibitory factor and mannose-binding lectin-2 gene poly-morphisms in acute rheumatic fever. Cardiol Young. 2012; [Epub ahead of print].
21. Pankuweit S, Ruppert V, Maisch B. Inflammation in dilated cardiomyopathy. Herz 2004; 29: 788-793.
22. Worthley DL, Bardy PG, Mullighan CG. Mannose-binding lectin: biology and clinical implications. Intern Med J. 2005; 35: 548-555.
23. Messias Reason LJ, Schafranski MD, Jensenius JC, et al. The association between mannose-binding lectin gene poymorphism and rheumatic hearth disease. Hum Immunol. 2006; 67: 991-998.
24. Ramasawmy R, Spina SG, Fae KC, et al. Association of mannose-binding lectin gene polymorphism but not of mannose-binding serine protease 2 with chronic severe aortic regurgitation of rheumatic etiology. Clin Vac-cine Immunol. 2008; 15: 932-936.
25. Schafranski MD, Ferrari LP, Scherner D, et al. High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever. Mol Immunol. 2008; 45: 3827-3831.
26. Horiuchi T, Tsukamoto H, Morita C, et al. Mannose-binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese. Genes Immun. 2000; 1: 464-466.
27. Leyva F, Anker SD, Godsland IF, et al. Uric acid in chronic heart failure: A marker of chronic inflammation. Eur Hearth J. 1998; 19: 1814-1822.
28. Kurata A, Shigematsu Y, Higaki J. Sex-related differences in relations of uric acid to left ventricular hypertrophy and remodeling in Japanese hypertensive patients. Hypertens Res. 2005; 28: 133-139.
29. Gullu H, Erdogan D, Caliskan M, et al. Elevated serum uric acid levels impair coronary microvascular function in patients with idiopathic cardiomiyopathy. Eur J Hearth Fail. 2007; 9: 466-468.
30. Garred P, Madsen HO, Marquarth H, et al. Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol. 2000; 27: 26-34.
31. De Benedetti FD, Meazza C, Vivarelli M, et al. The British Paediatric Rheumatology Study Group. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2003; 48: 1398-1407.
32. Donn R, Alourfi Z, De Benedetti F, et al. The British Paediatric Rheu-matology Study Group. Mutation screening of the macrophage migra-tion inhibitory factor gene. Positive association of a functional poly-morphism of macrophage migration inhibitory factor with juvenile idi-opathic arthritis. Arthritis Rheum. 2002; 46: 2402-2409
33. Nohara H, Okayama N, Inoune N, et al. Association of the 173G/C polymorphism of the macrophage migration inhibitory factor gene with ulserative colitis. J Gastroenterol. 2004; 39: 242-246.
34. Miller EJ, Li J, Leng L, et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic hearth. Nature 2008; 451: 578-582
35. Jian Z, Li JB, Ma RY, et al. Increase of macrophage migration inhibitory factor (MIF) expression in cardiomyocytes during chronic hypoxia. Clin Chim Acta. 2009; 405:132-138.
36. Tereshcenko IP, Petrkova J, Mrazek F, et al. The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian pa-tients with myocardial infarction. Clin Chim Acta. 2009; 402: 199-202.
37. Xie Q, Wang SC, Bian G, et al. Association of MIF -173G/C and MBL2 codon 54 gene polymorphisms with rheumatoid arthritis: a meta-analysis. Hum Immunol. 2012; [Epub ahead of print]
38. Pankuweit S, Ruppert V, Maisch B. Inflammation in dilated cardiomy-opathy. Herz 2004; 29: 788-793.
39. Bielecka-Dabrowa A, Wierzbicka M, Dabrowa M, et al. New methods in laboratory diagnostics of dilated cardiomiyopathy. Cardiol J. 2008; 15: 388-395.
40. Bettencourt PM. Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives. Hearth 2005; 91: 1489-1494.